Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain

Journal of Clinical Psychopharmacology

Volumn 33, Issue 1, 2013, Pages 74-79

  Czerwensky, Fabian ^a   Leucht, Stefan ^b   Steimer, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

antipsychotic therapy; human melanocortin 4 receptor gene MC4R; pharmacogenetic; weight gain

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; LITHIUM; MELANOCORTIN 4 RECEPTOR; MIRTAZAPINE; OLANZAPINE; PALIPERIDONE; PAROXETINE; QUETIAPINE; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENERGY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INPATIENTS; LINEAR MODELS; MALE; MIDDLE AGED; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 4; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WEIGHT GAIN; YOUNG ADULT;

EID: 84873083606     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31827772db     Document Type: Article

References (31)

1. Kane JM, Leucht S, Carpenter D, et al. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry. 2003;64(suppl 12):5-19.
2. Hugenholtz GW, Heerdink ER, Meijer WE, et al. Reasons for switching between antipsychotics in daily clinical practice. Pharmacopsychiatry. 2005;38:122-124.
3. Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res. 2004;66:51-57.
4. Muller DJ, Kennedy JL. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics. 2006;7:863-887.
5. Perusse L, Rankinen T, Zuberi A, et al. The human obesity gene map: the 2004 update. Obes Res. 2005;13:381-490.
6. Zhang JP, Malhotra AK. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Expert Opin Drug Metab Toxicol. 2011;7:9-37.
7. De Luca V, Mueller DJ, de Bartolomeis A, et al. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol. 2007;10:697-704.
8. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889-894.
9. Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40:716-718.
10. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768-775.
11. Sundaramurthy D, Campbell DA, Leek JP, et al. Assignment of the melanocortin 4 receptor (MC4R) gene to human chromosome band 18q22 by in situ hybridisation and radiation hybrid mapping. Cytogenet Cell Genet. 1998;82:97-98.
12. Gantz I, Miwa H, Konda Y, et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem. 1993;268:15174-15179.
13. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6:221-234.
14. Mountjoy KG, Mortrud MT, Low MJ, et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 1994;8:1298-1308.
15. Horvath TL. The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci. 2005;8:561-565.
16. Fan ZC, Tao YX. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. J Cell Mol Med. 2009;13:3268-3282.
17. Tao YX, Segaloff DL. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology. 2003;144:4544-4551.
18. Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol. 2005;239:1-14.
19. Beckers S, Zegers D, de Freitas F, et al. Association study of MC4R with complex obesity and replication of the rs17782313 association signal. Mol Genet Metab. 2011;103:71-75.
20. Cheung CY, Tso AW, Cheung BM, et al. Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur J Endocrinol. 2011;164: 381-388.
21. Valladares M, Dominguez-Vasquez P, Obregon AM, et al. Melanocortin-4 receptor gene variants in Chilean families: association with childhood obesity and eating behavior. Nutr Neurosci. 2010;13:71-78.
22. Drieling T, Biedermann NC, Scharer LO, et al. [Psychotropic drug-induced change of weight: a review]. Fortschr Neurol Psychiatr. 2007;75:65-80.
23. Popp J, Messner B, Steimer W. High-speed genotyping of CYP1A2&z.ast;1F mutation with fluorescent hybridization probes using the LightCycler. Pharmacogenomics. 2003;4: 643-646.
24. Bui M, Liu Z. Simple allele-discriminating PCR for cost-effective and rapid genotyping and mapping. Plant Methods. 2009;5:1.
25. Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, et al. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course. J Psychiatr Res. 2009;43:620-626.
26. Huang W, Sun Y, Sun J. Combined effects of FTO rs9939609 and MC4R rs17782313 on obesity and BMI in Chinese Han populations. Endocrine. 2011;39:69-74.
27. Balt SL, Galloway GP, Baggott MJ, et al. Mechanisms and genetics of antipsychotic-associated weight gain. Clin Pharmacol Ther. 2011;90:179-183.
28. Petry CJ, Lopez-Bermejo A, Diaz M, et al. Association between a common variant near MC4R and change in body mass index develops by two weeks of age. Horm Res Paediatr. 2010;73:275-280.
29. Vaisse C, Clement K, Guy-Grand B, et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998;20:113-114.
30. Yeo GS, Farooqi IS, Aminian S, et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 1998;20:111-112.
31. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature. 2007;447:655-660.